Poly Medicure (India) Performance
| POLYMED Stock | 2,692 72.10 2.61% |
On a scale of 0 to 100, Poly Medicure holds a performance score of 6. The company holds a Beta of -0.7, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Poly Medicure are expected to decrease at a much lower rate. During the bear market, Poly Medicure is likely to outperform the market. Please check Poly Medicure's value at risk, as well as the relationship between the kurtosis and market facilitation index , to make a quick decision on whether Poly Medicure's historical price patterns will revert.
Risk-Adjusted Performance
6 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Poly Medicure Limited are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain primary indicators, Poly Medicure exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Forward Dividend Yield 0.001 | Payout Ratio 0.098 | Last Split Factor 2:1 | Forward Dividend Rate 3 | Ex Dividend Date 2024-09-19 |
1 | Poly Medicure Ltds Stock Performance Soars, Receives Buy Call from MarketsMOJO - MarketsMojo | 11/13/2024 |
| Begin Period Cash Flow | 74.3 M |
Poly |
Poly Medicure Relative Risk vs. Return Landscape
If you would invest 233,545 in Poly Medicure Limited on August 30, 2024 and sell it today you would earn a total of 35,635 from holding Poly Medicure Limited or generate 15.26% return on investment over 90 days. Poly Medicure Limited is generating 0.2899% of daily returns and assumes 3.5671% volatility on return distribution over the 90 days horizon. Simply put, 31% of stocks are less volatile than Poly, and 95% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Poly Medicure Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Poly Medicure's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Poly Medicure Limited, and traders can use it to determine the average amount a Poly Medicure's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0813
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | POLYMED | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.57 actual daily | 31 69% of assets are more volatile |
Expected Return
| 0.29 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Poly Medicure is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Poly Medicure by adding it to a well-diversified portfolio.
Poly Medicure Fundamentals Growth
Poly Stock prices reflect investors' perceptions of the future prospects and financial health of Poly Medicure, and Poly Medicure fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Poly Stock performance.
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0882 | ||||
| Profit Margin | 0.19 % | ||||
| Operating Margin | 0.22 % | ||||
| Current Valuation | 293.22 B | ||||
| Shares Outstanding | 101.33 M | ||||
| Price To Book | 11.74 X | ||||
| Price To Sales | 18.40 X | ||||
| Revenue | 13.76 B | ||||
| Gross Profit | 7.06 B | ||||
| EBITDA | 4.2 B | ||||
| Net Income | 2.58 B | ||||
| Cash And Equivalents | 1.76 B | ||||
| Total Debt | 1.74 B | ||||
| Book Value Per Share | 266.96 X | ||||
| Cash Flow From Operations | 2.66 B | ||||
| Earnings Per Share | 30.62 X | ||||
| Total Asset | 18.59 B | ||||
| Retained Earnings | 7.31 B | ||||
About Poly Medicure Performance
By analyzing Poly Medicure's fundamental ratios, stakeholders can gain valuable insights into Poly Medicure's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Poly Medicure has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Poly Medicure has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Poly Medicure is entity of India. It is traded as Stock on NSE exchange.Things to note about Poly Medicure Limited performance evaluation
Checking the ongoing alerts about Poly Medicure for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Poly Medicure Limited help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Poly Medicure had very high historical volatility over the last 90 days | |
| Poly Medicure is unlikely to experience financial distress in the next 2 years | |
| About 67.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Paytm shares near 52-week high after 20 percent surge in the last five sessions - CNBCTV18 |
- Analyzing Poly Medicure's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Poly Medicure's stock is overvalued or undervalued compared to its peers.
- Examining Poly Medicure's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Poly Medicure's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Poly Medicure's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Poly Medicure's stock. These opinions can provide insight into Poly Medicure's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Poly Stock analysis
When running Poly Medicure's price analysis, check to measure Poly Medicure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Poly Medicure is operating at the current time. Most of Poly Medicure's value examination focuses on studying past and present price action to predict the probability of Poly Medicure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Poly Medicure's price. Additionally, you may evaluate how the addition of Poly Medicure to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |